X

Trial Profile

Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 26 Aug 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Meningococcal vaccine group C conjugate (Primary) ; Meningococcal vaccine group C conjugate (Primary) ; Meningococcal vaccine group C conjugate (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate (Primary) ; Hib-DTaP-poliovirus vaccine; Hib-meningococcal vaccine group C conjugate
Indications Meningococcal group C infections; Pneumococcal infections
Focus Pharmacodynamics

Most Recent Events

27 Mar 2012 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
27 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
01 Apr 2010 Results published in the Pediatric Infectious Disease Journal

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com